South East Asia Omega-3 Market - 2023-2031

November 2025 | 223 pages | ID: S7E9D71D4159EN
DataM Intelligence

US$ 2,999.00 US$ 4,350.00 -31 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The South East Asia Omega-3 Market was valued at US$ 157.6 million in 2023 and is anticipated to reach US$ 290.20 million by 2031, at a CAGR of 0.0793 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the South East Asia Omega-3 Market.

This report delivers a comprehensive overview of the South East Asia Omega-3 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding South East Asia Omega-3 Market. The South East Asia Omega-3 Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

South East Asia Omega-3 Market Scope:

By Source
  • Feed Source
  • Food Source
  • Pharma Source
By Type
  • ALA (Alpha-Linolenic Acid)
  • DHA (Docosahexaenoic Acid)
  • EPA (Eicosapentaenoic Acid)
  • Others
By Application
  • Supplements & Functional Foods
  • Pharmaceuticals
  • Infant Formula
  • Animal Feed & Pet Food
  • Others
By Distribution Channel
  • Online
  • Offline
Key Players
  • Thai Union Group PCL
  • Total Health Concept Sdn Bhd
  • BOSTON PHARMA VIETNAM
  • Moller’s
  • Manuka Biotech Sdn Bhd
  • ZUCHE PHARMACEUTICALS PVT. LTD
  • Novus Life Sciences Pvt Ltd
  • NOW Health Group, Inc.
  • BASF SE
  • Croda International Plc
Major Highlights

This report delivers a comprehensive overview of the South East Asia Omega-3 Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding South East Asia Omega-3 Market. The South East Asia Omega-3 Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
  • Increase Your Customer Base by 3X using our Partner Identification tool
  • Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
  • Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
  • Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Source
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by Distribution Channel

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Diverse Product Formats
    4.1.1.2. Increasing Dietary Trends
  4.1.2. Restraints
    4.1.2.1. Threats from Substitutes for the Omega-3
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Supply Chain Analysis
5.8. Value Chain Analysis
5.9. GO-TO-Market Strategy
5.10. Import and Export Analysis
5.11. Consumer Analysis
  5.11.1. Consumer Pain Points
  5.11.2. Consumer Needs
5.12. DMI Opinion

6. BY SOURCE

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  6.1.2. Market Attractiveness Index, By Source
6.2. Feed Source*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Food Source
6.4. Pharma Source

7. BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. ALA (Alpha-Linolenic Acid)
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. DHA (Docosahexaenoic Acid)
7.4. EPA (Eicosapentaenoic Acid)
7.5. Others

8. BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Supplements & Functional Foods*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pharmaceuticals
8.4. Infant Formula
8.5. Animal Feed & Pet Food
8.6. Others

9. BY DISTRIBUTION CHANNEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Offline

10. SUSTAINABILITY ANALYSIS

10.1. Environmental Analysis
10.2. Economic Analysis
10.3. Governance Analysis

11. COMPETITIVE LANDSCAPE

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. COMPANY PROFILES

12.1. Thai Union Group PCL *
  12.1.1. Company Overview
  12.1.2. Type Portfolio and Description
  12.1.3. Financial Overview
  12.1.4. Key Developments
12.2. Total Health Concept Sdn Bhd
12.3. BOSTON PHARMA VIETNAM
12.4. M?ller’s
12.5. Manuka Biotech Sdn Bhd
12.6. ZUCHE PHARMACEUTICALS PVT. LTD
12.7. Novus Life Sciences Pvt Ltd
12.8. NOW Health Group, Inc.
12.9. BASF SE
12.10. Croda International Plc (*LIST NOT EXHAUSTIVE)

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us


More Publications